Challenges and opportunities in cancer drug resistance

RA Ward, S Fawell, N Floc'h, V Flemington… - Chemical …, 2020 - ACS Publications
There has been huge progress in the discovery of targeted cancer therapies in recent years.
However, even for the most successful and impactful cancer drugs which have been …

Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

S Vatansever, A Schlessinger, D Wacker… - Medicinal research …, 2021 - Wiley Online Library
Neurological disorders significantly outnumber diseases in other therapeutic areas.
However, developing drugs for central nervous system (CNS) disorders remains the most …

CancerGPT for few shot drug pair synergy prediction using large pretrained language models

T Li, S Shetty, A Kamath, A Jaiswal, X Jiang… - NPJ Digital …, 2024 - nature.com
Large language models (LLMs) have been shown to have significant potential in few-shot
learning across various fields, even with minimal training data. However, their ability to …

SNRMPACDC: computational model focused on Siamese network and random matrix projection for anticancer synergistic drug combination prediction

TH Li, CC Wang, L Zhang, X Chen - Briefings in Bioinformatics, 2023 - academic.oup.com
Synergistic drug combinations can improve the therapeutic effect and reduce the drug
dosage to avoid toxicity. In previous years, an in vitro approach was utilized to screen …

Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction

X Liu, C Song, S Liu, M Li, X Zhou, W Zhang - Bioinformatics, 2022 - academic.oup.com
Motivation Drug combinations have exhibited promise in treating cancers with less toxicity
and fewer adverse reactions. However, in vitro screening of synergistic drug combinations is …

Drug repurposing for cancer therapy

Y Xia, M Sun, H Huang, WL Jin - Signal Transduction and Targeted …, 2024 - nature.com
Cancer, a complex and multifactorial disease, presents a significant challenge to global
health. Despite significant advances in surgical, radiotherapeutic and immunological …

SYNPRED: prediction of drug combination effects in cancer using different synergy metrics and ensemble learning

AJ Preto, P Matos-Filipe, J Mourão, IS Moreira - GigaScience, 2022 - academic.oup.com
Background In cancer research, high-throughput screening technologies produce large
amounts of multiomics data from different populations and cell types. However, analysis of …

Machine learning approaches for drug combination therapies

B Güvenç Paltun, S Kaski… - Briefings in …, 2021 - academic.oup.com
Drug combination therapy is a promising strategy to treat complex diseases such as cancer
and infectious diseases. However, current knowledge of drug combination therapies …

[HTML][HTML] Computer-aided drug repurposing for cancer therapy: approaches and opportunities to challenge anticancer targets

C Mottini, F Napolitano, Z Li, X Gao… - Seminars in cancer biology, 2021 - Elsevier
Despite huge efforts made in academic and pharmaceutical worldwide research, current
anticancer therapies achieve effective treatment in a limited number of neoplasia cases only …

CCSynergy: an integrative deep-learning framework enabling context-aware prediction of anti-cancer drug synergy

SR Hosseini, X Zhou - Briefings in bioinformatics, 2023 - academic.oup.com
Combination therapy is a promising strategy for confronting the complexity of cancer.
However, experimental exploration of the vast space of potential drug combinations is costly …